• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CRISPR/Cas9 介导的基因编辑新兴物理转染方法综述。

A review of emerging physical transfection methods for CRISPR/Cas9-mediated gene editing.

机构信息

Paul M. Rady Department of Mechanical Engineering, University of Colorado Boulder, Boulder, CO, 80309, USA.

University Medical Center Groningen, University of Groningen, Groningen, The Netherland.

出版信息

Theranostics. 2020 Apr 15;10(12):5532-5549. doi: 10.7150/thno.43465. eCollection 2020.

DOI:10.7150/thno.43465
PMID:32373229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7196308/
Abstract

Gene editing is a versatile technique in biomedicine that promotes fundamental research as well as clinical therapy. The development of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) as a genome editing machinery has accelerated the application of gene editing. However, the delivery of CRISPR components often suffers when using conventional transfection methods, such as viral transduction and chemical vectors, due to limited packaging size and inefficiency toward certain cell types. In this review, we discuss physical transfection methods for CRISPR gene editing which can overcome these limitations. We outline different types of physical transfection methods, highlight novel techniques to deliver CRISPR components, and emphasize the role of micro and nanotechnology to improve transfection performance. We present our perspectives on the limitations of current technology and provide insights on the future developments of physical transfection methods.

摘要

基因编辑是生物医学中一种通用的技术,它促进了基础研究和临床治疗。作为一种基因组编辑工具,簇状规律间隔短回文重复序列(CRISPR)的发展加速了基因编辑的应用。然而,由于包装大小有限以及对某些细胞类型的效率低下,传统的转染方法(如病毒转导和化学载体)在使用时经常会遇到 CRISPR 组件的传递问题。在这篇综述中,我们讨论了用于 CRISPR 基因编辑的物理转染方法,这些方法可以克服这些限制。我们概述了不同类型的物理转染方法,强调了用于递送 CRISPR 组件的新技术,并强调了微纳技术在提高转染性能方面的作用。我们提出了对当前技术局限性的看法,并对物理转染方法的未来发展提供了见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5698/7196308/36c445fef1eb/thnov10p5532g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5698/7196308/c041b9674e3d/thnov10p5532g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5698/7196308/e3a088f26cca/thnov10p5532g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5698/7196308/c46dcc9995fa/thnov10p5532g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5698/7196308/151c7d2a00b6/thnov10p5532g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5698/7196308/36c445fef1eb/thnov10p5532g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5698/7196308/c041b9674e3d/thnov10p5532g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5698/7196308/e3a088f26cca/thnov10p5532g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5698/7196308/c46dcc9995fa/thnov10p5532g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5698/7196308/151c7d2a00b6/thnov10p5532g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5698/7196308/36c445fef1eb/thnov10p5532g005.jpg

相似文献

1
A review of emerging physical transfection methods for CRISPR/Cas9-mediated gene editing.CRISPR/Cas9 介导的基因编辑新兴物理转染方法综述。
Theranostics. 2020 Apr 15;10(12):5532-5549. doi: 10.7150/thno.43465. eCollection 2020.
2
In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.用于治疗性基因编辑的CRISPR/Cas9体内递送:进展与挑战
Bioconjug Chem. 2017 Apr 19;28(4):880-884. doi: 10.1021/acs.bioconjchem.7b00057. Epub 2017 Mar 17.
3
Therapeutic Genome Editing and In Vivo Delivery.治疗性基因组编辑与体内递送。
AAPS J. 2021 Jun 2;23(4):80. doi: 10.1208/s12248-021-00613-w.
4
Delivery of CRISPR/Cas9 for therapeutic genome editing.CRISPR/Cas9 基因编辑治疗的递送。
J Gene Med. 2019 Jul;21(7):e3107. doi: 10.1002/jgm.3107.
5
CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.基于 CRISPR/Cas9 的基因组编辑在疾病建模和治疗中的应用:非病毒递送的挑战和机遇。
Chem Rev. 2017 Aug 9;117(15):9874-9906. doi: 10.1021/acs.chemrev.6b00799. Epub 2017 Jun 22.
6
Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.基因治疗与 CRISPR/Cas9 渐趋成熟,有望攻克 HIV。
AIDS Rev. 2017 Oct-Dec;19(3):167-172.
7
Applications of CRISPR-Cas9 Technology to Genome Editing in Glioblastoma Multiforme.CRISPR-Cas9 技术在多形性胶质母细胞瘤基因组编辑中的应用。
Cells. 2021 Sep 7;10(9):2342. doi: 10.3390/cells10092342.
8
Delivery approaches for CRISPR/Cas9 therapeutics in vivo: advances and challenges.体内 CRISPR/Cas9 治疗的递送方法:进展与挑战。
Expert Opin Drug Deliv. 2018 Sep;15(9):905-913. doi: 10.1080/17425247.2018.1517746. Epub 2018 Sep 12.
9
Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing.近期非病毒 CRISPR/Cas9 基因编辑递送和应用的进展。
Drug Deliv Transl Res. 2023 May;13(5):1500-1519. doi: 10.1007/s13346-023-01320-z. Epub 2023 Mar 29.
10
Pre-clinical non-viral vectors exploited for CRISPR/Cas9 gene editing: an overview.用于 CRISPR/Cas9 基因编辑的临床前非病毒载体:概述。
Biomater Sci. 2022 Jun 28;10(13):3410-3432. doi: 10.1039/d1bm01452h.

引用本文的文献

1
Stimuli-Responsive, Cell-Mediated Drug Delivery Systems: Engineering Smart Cellular Vehicles for Precision Therapeutics.刺激响应型细胞介导药物递送系统:构建用于精准治疗的智能细胞载体
Pharmaceutics. 2025 Aug 21;17(8):1082. doi: 10.3390/pharmaceutics17081082.
2
Limited Efficacy of Nanoparticle-Assisted Electroporation for Membrane Permeabilization and Gene Electrotransfer.纳米颗粒辅助电穿孔用于膜通透化和基因电转染的疗效有限。
Pharmaceutics. 2025 Jul 25;17(8):964. doi: 10.3390/pharmaceutics17080964.
3
Small Extracellular Vesicles in Neurodegenerative Disease: Emerging Roles in Pathogenesis, Biomarker Discovery, and Therapy.

本文引用的文献

1
Transfection with nanostructure electro-injection is minimally perturbative.采用纳米结构电注射进行转染对细胞的扰动极小。
Adv Ther (Weinh). 2019 Dec;2(12). doi: 10.1002/adtp.201900133. Epub 2019 Sep 30.
2
Engineered materials for in vivo delivery of genome-editing machinery.用于体内递送基因组编辑机制的工程材料。
Nat Rev Mater. 2019 Nov;4:726-737. doi: 10.1038/s41578-019-0145-9. Epub 2019 Oct 4.
3
Cas9 Ribonucleoprotein Delivery via Microfluidic Cell-Deformation Chip for Human T-Cell Genome Editing and Immunotherapy.通过微流控细胞变形芯片递送Cas9核糖核蛋白用于人类T细胞基因组编辑和免疫治疗
神经退行性疾病中的细胞外小泡:在发病机制、生物标志物发现及治疗中的新作用
Int J Mol Sci. 2025 Jul 26;26(15):7246. doi: 10.3390/ijms26157246.
4
Targeted RNA editing by direct delivery of an adenosine deaminase-antisense oligo conjugate.通过直接递送腺苷脱氨酶-反义寡核苷酸共轭物进行靶向RNA编辑。
bioRxiv. 2025 Jul 12:2025.07.11.664364. doi: 10.1101/2025.07.11.664364.
5
Light-controlled genome editing by activation of Cas9-mRNA translation.通过激活Cas9 - mRNA翻译实现光控基因组编辑。
Chem Sci. 2025 Jun 30. doi: 10.1039/d5sc01999k.
6
Ultrasound-Mediated Membrane Modulation for Biomedical Applications.用于生物医学应用的超声介导膜调制
Nanomaterials (Basel). 2025 Jun 7;15(12):884. doi: 10.3390/nano15120884.
7
An innovative approach using CRISPR-ribonucleoprotein packaged in virus-like particles to generate genetically engineered mouse models.一种创新方法,利用包装在病毒样颗粒中的CRISPR核糖核蛋白来生成基因工程小鼠模型。
Nat Commun. 2025 Apr 11;16(1):3451. doi: 10.1038/s41467-025-58364-7.
8
Current and future treatments for sickle cell disease: From hematopoietic stem cell transplantation to in vivo gene therapy.镰状细胞病的当前及未来治疗方法:从造血干细胞移植到体内基因治疗。
Mol Ther. 2025 May 7;33(5):2172-2191. doi: 10.1016/j.ymthe.2025.03.016. Epub 2025 Mar 12.
9
Circular Vectors as an efficient, fully synthetic, cell-free approach for preparing small circular DNA as a plasmid substitute for guide RNA expression in CRISPR-Cas9 genome editing.环状载体作为一种高效、完全合成的无细胞方法,用于制备小环状DNA,作为CRISPR-Cas9基因组编辑中引导RNA表达的质粒替代物。
Nat Protoc. 2025 Feb 24. doi: 10.1038/s41596-024-01138-0.
10
Focused-ultrasound-mediated CRISPR-Cas9 gene editing in human induced pluripotent stem cells.聚焦超声介导的人诱导多能干细胞中的CRISPR-Cas9基因编辑
Mol Ther. 2025 Mar 5;33(3):831-832. doi: 10.1016/j.ymthe.2025.02.006. Epub 2025 Feb 20.
Adv Biosyst. 2017 Feb;1(1-2):e1600007. doi: 10.1002/adbi.201600007. Epub 2017 Jan 16.
4
Gene delivery to mammalian cells using a graphene nanoribbon platform.使用石墨烯纳米带平台将基因递送至哺乳动物细胞。
J Mater Chem B. 2017 Mar 28;5(12):2347-2354. doi: 10.1039/c6tb03010f. Epub 2017 Mar 14.
5
The effects of electroporation buffer composition on cell viability and electro-transfection efficiency.电穿孔缓冲液组成对细胞活力和电转染效率的影响。
Sci Rep. 2020 Feb 20;10(1):3053. doi: 10.1038/s41598-020-59790-x.
6
CRISPR-engineered T cells in patients with refractory cancer.经 CRISPR 基因编辑的 T 细胞治疗难治性癌症的患者。
Science. 2020 Feb 28;367(6481). doi: 10.1126/science.aba7365. Epub 2020 Feb 6.
7
RNA Nanotechnology-Mediated Cancer Immunotherapy.RNA 纳米技术介导的癌症免疫疗法。
Theranostics. 2020 Jan 1;10(1):281-299. doi: 10.7150/thno.35568. eCollection 2020.
8
Adeno-associated viral vector-mediated immune responses: Understanding barriers to gene delivery.腺相关病毒载体介导的免疫反应:理解基因传递的障碍。
Pharmacol Ther. 2020 Mar;207:107453. doi: 10.1016/j.pharmthera.2019.107453. Epub 2019 Dec 11.
9
Search-and-replace genome editing without double-strand breaks or donor DNA.无双链断裂或供体 DNA 的搜索和替换基因组编辑。
Nature. 2019 Dec;576(7785):149-157. doi: 10.1038/s41586-019-1711-4. Epub 2019 Oct 21.
10
CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia.经 CRISPR 编辑的干细胞在一名 HIV 合并急性淋巴细胞白血病患者中的应用。
N Engl J Med. 2019 Sep 26;381(13):1240-1247. doi: 10.1056/NEJMoa1817426. Epub 2019 Sep 11.